⌘K

Login Start Free

Home/Filings/4/0001571049-14-004087

4//SEC Filing

NephroGenex, Inc. 4

Accession 0001571049-14-004087

CIK 0001338095operating

View on SEC.gov Company Profile

Filed

Aug 14, 8:00 PM ET

Accepted

Aug 15, 4:42 PM ET

Size

5.6 KB

Accession

0001571049-14-004087

Insider Transaction Report

Form 4

Period: 2014-08-14

NephroGenex, Inc.NRX

Chief Financial Officer

Transactions

Award
Options to Purchase Common Stock
2014-08-14+24,000→ 24,000 total
Exercise: $4.49→ Common Stock (24,000 underlying)

Footnotes (1)

[F1]25% of the shares underlying the options will vest on August 14, 2015, and the remainder of the shares underlying the options will vest on a pro rata monthly basis for a three-year period following August 14, 2015.

Documents

1 file

4
t1401601_hamill-f4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

NephroGenex, Inc.

CIK 0001338095

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001338095

Filing Metadata

Form type: 4
Filed: Aug 14, 8:00 PM ET
Accepted: Aug 15, 4:42 PM ET
Size: 5.6 KB

View on SEC.gov